3% of medicines are of poor quality: Survey

The survey found that out of the 47,012 samples tested, 13 samples were spurious and 1,850 samples were not of standard quality (NSQ).

GN Bureau | February 25, 2017


#Health ministry   #medicines   #poor quality   #spurious   #India news  

 More than three percent of medicines in India are ‘Not of Standard Quality’ (NSQ) and 0.0245 percent spurious, reveals a survey report on drugs quality by the ministry of health. 

The survey carried out by National Institute of Biologicals (NIB), Noida found that out of the 47,012 samples tested, 13 samples were spurious and 1,850 samples were NSQ.  
 
It is the largest ever scientifically designed and professionally executed drug survey undertaken in the world for determining the quality of drugs, a press statement released by the ministry said.
 
 
It included as many as 224 drug molecules belonging to 15 different therapeutic categories of the National List of Essential Medicines (NLEM) 2011. As part of this survey, 47,954 drug samples relating to 23 dosage forms were drawn from 654 districts of 36 states and union territories from the supply chains including retail outlets, government sources and from eight airports and sea ports.
 
All the samples were subjected to test and analysis in the central and state drug testing laboratories that have been accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL).  A nationwide training in drugs survey methodology was imparted at 28 centres across the country to over 1800 Sample Drawing Officers (SDOs) and representatives of the Civil society / pharmacy council of India (PCI). 
 
They observed that the drugs samples are drawn in accordance with the sampling methodology and the highest degree of transparency and objectivity is maintained in the process to eliminate any bias.
 

 

Comments

 

Other News

Remdesivir procured at high prices to save lives: BMC

Countering the opposition BJP’s allegations of corruption in the procurement of Remdesivir, a critical anti-viral injection often prescribed for Covid-19 patients, the BrihanMumbai municipal corporation (BMC) has clarified that its decision to procure the drug was aimed at saving  lives even if

“Not appropriate to postpone Class XII CBSE exams”

Criticizing the postponement of the CBSE Class XII exams in the wake of the second Covid -19 wave across the country, Nupur Sharma, BJP national spokesperson, has said the decision will jeopardize the future of students. Despite the pandemic she said no college or university will be ready to give them prov

Govt announces strategic collaboration to empower Atal Tinkering Lab schools

Atal Innovation Mission, NITI Aayog and All India Council for Technical Education (AICTE), and Ministry of Education’s Innovation Cell has announced their strategic collaboration which aims to empower Atal Tinkering Lab school (ATLs) students for world-class future-ready

Agriculture Min signs MoU with Microsoft to develop smart interface for farmers

Union Ministry of Agriculture and Microsoft India has inked a Memorandum of Understanding (MoU) for a pilot project in 100 villages of six states to develop farmer interface for smart and well-organized agriculture, including post-harvest management and distribution. The pilot

NIXI inaugurates new initiatives to improve IPV6 adoption

Ajay Prakash Sawhney, Secretary Ministry of Electronics & Information Technology (MeitY) & Chairman NIXI has inaugurated three initiatives of the National Internet Exchange of India (NIXI). With this launch, NIXI has announced to play a supporting role for the IPv6 aw

India’s Second Wave crosses 2-lakh milestone

The Second Wave in India seems unstoppable. The number of daily new cases crossed the 2,00,000 figure on Thursday morning, which is the highest ever anywhere in the world. Most of the burden – 81 percent cases – is from ten states with Maharashtra continuing to lead the tally. The national capi

Visionary talk series with Nupur Sharma, National Spokesperson, BJP



Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter